California Public Employees Retirement System’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-50,696
Closed -$16M 1201
2023
Q4
$16M Hold
50,696
0.01% 690
2023
Q3
$8.57M Sell
50,696
-8,177
-14% -$1.54M 0.01% 900
2023
Q2
$12.8M Buy
58,873
+4,419
+8% +$947K 0.01% 750
2023
Q1
$9.89M Buy
54,454
+9,128
+20% +$1.75M 0.01% 864
2022
Q4
$8.91M Buy
45,326
+818
+2% +$175K 0.01% 942
2022
Q3
$10M Buy
+44,508
New +$9.01M 0.01% 873
2021
Q2
Sell
-32,100
Closed -$3.86M 3110
2021
Q1
$3.86M Hold
32,100
﹤0.01% 1584
2020
Q4
$3.26M Sell
32,100
-3,628
-10% -$336K ﹤0.01% 1687
2020
Q3
$2.76M Buy
35,728
+1,400
+4% +$119K ﹤0.01% 1638
2020
Q2
$3.83M Buy
34,328
+19,739
+135% +$1.72M ﹤0.01% 1360
2020
Q1
$1.05M Buy
14,589
+3,300
+29% +$282K ﹤0.01% 1983
2019
Q4
$851K Buy
+11,289
New +$494K ﹤0.01% 2462

Other funds holding KRTX

California Public Employees Retirement System's KRTX Position: Q1 2024 in Review

California Public Employees Retirement System sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 50,696 shares — an estimated $16M sold.

California Public Employees Retirement System first reported a position in KRTX in Q4 2019 and held it in 12 quarters. The position peaked at $16M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • California Public Employees Retirement System reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • California Public Employees Retirement System sold 50,696 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $16M.
  • California Public Employees Retirement System first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2019 and held it in 12 quarters.
  • California Public Employees Retirement System's Karuna Therapeutics, Inc. Common Stock position peaked at $16M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on California Public Employees Retirement System's 13F filing for Q1 2024, filed 30 Apr 2024.